Drug Safety Update
April 2008: Carbamazepine higher risk of Stevens -Johnson syndrome in some Asian populations genetic testing is recommended - see also Dec 2012 update below
December 2012: Carbamazepine, oxcarbazepine and eslicarbazepine potential risk of serious skin reactions
October 2017: Gabapentin: risk of severe respiratory depression even without concomitant opioid medicines.
April 2019: Pregabalin (Lyrica), gabapentin (Neurontin) and risk of abuse and dependence: new scheduling requirements from 1 April
CG 173 Neuropathic pain in adults: pharmacological management in non-specialist settings, updated April 2018
Trust Guidelines for the management of neuropathic pain in adults, June 2017